|
1
|
Trayhurn P and Beattie JH: Physiological
role of adipose tissue: white adipose tissue as an endocrine and
secretory organ. Proc Nutr Soc. 60:329–339. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ,
et al: The adipocyte: a model for integration of endocrine and
metabolic signaling in energy metabolism regulation. Am J Physiol
Endocrinol Metab. 280:E827–E847. 2001.PubMed/NCBI
|
|
3
|
Berg AH and Scherer PE: Adipose tissue,
inflammation, and cardiovascular disease. Circ Res. 96:939–949.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hotamisligil GS, Arner P, Caro JF, et al:
Increased adipose tissue expression of tumor necrosis factor-alpha
in human obesity and insulin resistance. J Clin Invest.
95:2409–2415. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hotamisligil GS, Shargill NS and
Spiegelman BM: Adipose expression of tumor necrosis factor-alpha:
direct role in obesity-linked insulin resistance. Science.
259:87–91. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kern PA, Ranganathan S, Li C, et al:
Adipose tissue tumor necrosis factor and interleukin-6 expression
in human obesity and insulin resistance. Am J Physiol Endocrinol
Metab. 280:E745–E751. 2001.PubMed/NCBI
|
|
7
|
Souza SC, Palmer HJ, Kang YH, et al:
TNF-alpha induction of lipolysis is mediated through activation of
the extracellular signal related kinase pathway in 3T3-L1
adipocytes. J Cell Biochem. 89:1077–1086. 2003. View Article : Google Scholar
|
|
8
|
Zhang B, Berger J, Hu E, et al: Negative
regulation of peroxisome proliferator-activated receptor-gamma gene
expression contributes to the antiadipogenic effects of tumor
necrosis factor-alpha. Mol Endocrinol. 10:1457–1466. 1996.
|
|
9
|
Hotamisligil GS, Budavari A, Murray D, et
al: Reduced tyrosine kinase activity of the insulin receptor in
obesity-diabetes. Central role of tumor necrosis factor-alpha. J
Clin Invest. 94:1543–1549. 1994. View Article : Google Scholar
|
|
10
|
Hotamisligil GS, Peraldi P, Budavari A, et
al: IRS-1-mediated inhibition of insulin receptor tyrosine kinase
activity in TNF-alpha- and obesity-induced insulin resistance.
Science. 271:665–668. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamauchi T, Hara K, Kubota N, et al: Dual
roles of adiponectin/Acrp30 in vivo as an anti-diabetic and
anti-atherogenic adipokine. Curr Drug Targets Immune Endocr Metabol
Disord. 3:243–253. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu X, Motoshima H, Mahadev K, et al:
Involvement of AMP-activated protein kinase in glucose uptake
stimulated by the globular domain of adiponectin in primary rat
adipocytes. Diabetes. 52:1355–1363. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hotta K, Funahashi T, Bodkin NL, et al:
Circulating concentrations of the adipocyte protein adiponectin are
decreased in parallel with reduced insulin sensitivity during the
progression to type 2 diabetes in rhesus monkeys. Diabetes.
50:1126–1133. 2001. View Article : Google Scholar
|
|
14
|
Hotta K, Funahashi T, Arita Y, et al:
Plasma concentrations of a novel, adipose-specific protein,
adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc
Biol. 20:1595–1599. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lihn AS, Richelsen B, Pedersen SB, et al:
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS:
implications for reduced adiponectin expression and plasma levels.
Am J Physiol Endocrinol Metab. 285:E1072–E1080. 2003.PubMed/NCBI
|
|
16
|
Ajuwon KM and Spurlock ME: Adiponectin
inhibits LPS-induced NF-kappaB activation and IL-6 production and
increases PPARgamma2 expression in adipocytes. Am J Physiol Regul
Integr Comp Physiol. 288:R1220–R1225. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fasshauer M, Klein J, Neumann S, et al:
Hormonal regulation of adiponectin gene expression in 3T3-L1
adipocytes. Biochem Biophys Res Commun. 290:1084–1089. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee YH and Pratley RE: The evolving role
of inflammation in obesity and the metabolic syndrome. Current Diab
Rep. 5:70–75. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heilbronn LK and Campbell LV: Adipose
tissue macrophages, low grade inflammation and insulin resistance
in human obesity. Curr Pharm Des. 14:1225–1230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Monzillo LU, Hamdy O, Horton ES, et al:
Effect of lifestyle modification on adipokine levels in obese
subjects with insulin resistance. Obes Res. 11:1048–1054. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fontana L, Eagon JC, Trujillo ME, et al:
Visceral fat adipokine secretion is associated with systemic
inflammation in obese humans. Diabetes. 56:1010–1013. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fain JN, Madan AK, Hiler ML, et al:
Comparison of the release of adipokines by adipose tissue, adipose
tissue matrix, and adipocytes from visceral and subcutaneous
abdominal adipose tissues of obese humans. Endocrinology.
145:2273–2282. 2004. View Article : Google Scholar
|
|
23
|
Kern PA, Di Gregorio GB, Lu T, et al:
Adiponectin expression from human adipose tissue relation to
obesity, insulin resistance, and tumor necrosis factor-alpha
expression. Diabetes. 52:1779–1785. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maeda N, Shimomura I, Kishida K, et al:
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.
Nat Med. 8:731–737. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujishiro M, Gotoh Y, Katagiri H, et al:
Three mitogen-activated protein kinases inhibit insulin signaling
by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol.
17:487–497. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim KY, Kim JK, Jeon JH, et al: c-Jun
N-terminal kinase is involved in the suppression of adiponectin
expression by TNF-alpha in 3T3-L1 adipocytes. Biochem Biophys Res
Commun. 327:460–467. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao T, Hou M, Xia M, et al: Globular
adiponectin decreases leptin-induced tumor necrosis factor-alpha
expression by murine macrophages: involvement of cAMP-PKA and MAPK
pathways. Cell Immunol. 238:19–30. 2005. View Article : Google Scholar
|
